On April 3, 2023, the United States HHS released detailed information for a National Cancer Plan. The plan aims to facilitate the Cancer Moonshot initiative. The Biden administration reignited the...
On March 24, 2023, the FDA issued a draft guidance on the clinical trial considerations for the accelerated approval of oncology drugs. The proposed recommendations include guidelines to fortify and...
Earlier this year, Nectin Therapeutics Ltd, a clinical biotechnology company, announced a collaboration with Merck, a leading global pharmaceutical company, to develop a treatment regimen for cancer patients. The clinical trial combines a...
In a study published in Nature on March 15, 2023, researchers achieved complete or nearly complete remission in 18 patients with KMT2A-rearranged or NPMI-mutant leukemia. The phase 1 clinical trial...
Recently, Pfizer Inc, a leading pharmaceutical manufacturer in the United States, confirmed plans to acquire Seagen, a smaller manufacturer focused on oncology medications, to expand its oncology portfolio, Pfizer Oncology. The recent...
After speculation about acquisition deals earlier this month, Pfizer Inc has officially confirmed its acquisition of Seagen Inc. The $43 billion deal was a strategic move by Pfizer to expand the...
Pfizer Inc is reportedly in talks to buy the cancer drugmaker Seagen Inc after a potential acquisition by Merck last year fell through. In August 2022, it was reported that Merck was considering a $40...
The Cleveland Clinic recently announced that it would begin enrolling patients for its phase 1b breast cancer vaccine study. The study will focus on cancer-free patients at risk of developing cancer,...
Early phase studies by scientists at the University of Washington found that a plasmid DNA breast cancer vaccine may produce favorable outcomes, generating anti-tumor immunity. The study, published in...
Throughout the COVID-19 pandemic, patients, researchers, and providers became increasingly familiar with mRNA vaccines, which have unparalleled public health benefits. While mRNA vaccines have been researched for years, the rapid...
Earlier this year, the United States Environmental Protection Agency (EPA) announced plans to propose, establish, and enforce national drinking water regulations for perfluorooctanoic acid (PFOA),...
According to a recent press release, Janssen recently submitted a Biologics License Application (BLA) to the FDA for talquetamab to treat relapsed or refractory multiple myeloma. The CDC states that...
Clarity Pharmaceuticals recently announced its Investigational New Drug (IND) approval from the FDA to test theranostic SAR-Bombesin for prostate cancer. Prostate cancer is the fifth leading cause of...
The American Cancer Society states that ovarian cancer is the fifth leading cause of cancer-related death in women in the United States. The organization also says that, in 2022, nearly 13,000 people...
In recent years, remote patient monitoring tools have gained traction as they have been introduced and integrated into patient care. The uptick in the use of remote patient monitoring tools and platforms was driven, in part, by travel...
